TORONTO, ONTARIO -- (Marketwired) -- 02/09/15 -- NEXGENRX INC. ("NexgenRx" or the "Corporation") (TSX VENTURE: NXG) announces the retirement of John Hawkrigg from his position as a director of the Corporation. Mr. Hawkrigg has served as a director of the Company for the past nine years.
Thomas Corcoran, Chairman of the Board of Directors of the Corporation stated: "On behalf of the Company and the Board of Directors, we wish to recognize the exemplary contributions that John has made to the Company over its formative years, to express our most sincere thanks to him for his great support and insight throughout his service as a director of NexgenRx and to wish him best regards in all of his future endeavours."
About NexgenRx
NexgenRx is a growing health benefits management company engaged in the design, management and administration of health benefit plans offered by employers and other plan sponsors for the benefit of their employees and plan members. More information on NexgenRx can be found at www.nexgenrx.com.
Caution Regarding Forward-Looking Statements - This news release contains certain forward looking statements, including statements regarding the business and anticipated financial performance of the Corporation. These statements are subject to a number of risks and uncertainties. Actual results may differ materially from results contemplated by the forward-looking statements. When relying on forward-looking statements to make decisions, investors and others should carefully consider the foregoing factors and other uncertainties and should not place undue reliance on such forward-looking statements.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the release.
Contacts:
NexgenRx Inc.
Ronald C. Loucks
President and CEO
416.695.3393 x801
NexgenRx Inc.
Taba Merrikh
Director of Finance
416-695-3393x803
